论文信息 - Uncertainty about postmenopausal estrogen. Time for action, not debate.

Uncertainty about postmenopausal estrogen. Time for action, not debate.

Despite the important epidemiologic evidence provided by Dr. Stampfer and his colleagues in this issue of the Journal 1 of the apparently protective effect of postmenopausal estrogen-replacement th...

A. Tosteson | L. Goldman

[1] J. Manson,et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. , 1991, The New England journal of medicine.

[2] B Healy,et al. The Yentl syndrome. , 1991, The New England journal of medicine.

[3] G. Colditz,et al. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆ , 1991 .

[4] M. Christiansen,et al. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives , 1991 .

[5] T. Bush. The Epidemiology of Cardiovascular Disease in Postmenopausal Women , 1990, Annals of the New York Academy of Sciences.

[6] D. Eddy. Screening for breast cancer. , 1989, Annals of internal medicine.

[7] D. Kiel,et al. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. , 1987, The New England journal of medicine.

[8] S G Pauker,et al. Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered. , 1986, The American journal of medicine.

[9] M. Weinstein,et al. Cost-effectiveness of hormone replacement therapy in the menopause. , 1983, Obstetrical & gynecological survey.